At a glance: AOD-9604 vs semaglutide
- Regulatory status: Semaglutide is TGA-approved (Ozempic for type 2 diabetes; Wegovy for weight management). AOD-9604 is not approved for obesity.
- Evidence for weight loss: Semaglutide shows consistent, clinically meaningful weight loss in large trials. AOD-9604 lacks robust human evidence for significant weight loss.
- How they work: AOD-9604 is an hGH fragment with proposed lipolysis effects; semaglutide is a GLP-1 receptor agonist that reduces appetite, improves satiety and glycaemia.
- Safety: Semaglutide has a well-characterised safety profile; AOD-9604 safety data are limited and grey-market quality control is a concern.
- Access in Australia: Semaglutide requires a prescription; AOD-9604 use occurs via unapproved pathways—be cautious of online sellers.
What they are and how they work
AOD-9604
AOD-9604 is a synthetic peptide fragment of human growth hormone (hGH 176-191). It is marketed for “fat burning” via proposed mechanisms that increase lipolysis and reduce lipogenesis. Despite online claims, high-quality human trials showing meaningful, sustained weight loss are lacking.
Learn more: What Is AOD-9604? · AOD-9604 Benefits · AOD-9604 for Fat Loss
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite, slows gastric emptying and improves blood glucose. It is TGA-approved as Ozempic (type 2 diabetes) and Wegovy (chronic weight management). Weight loss is primarily driven by lower energy intake and improved satiety.
Learn more: What Is Semaglutide? · Semaglutide for Weight Loss · GLP-1 Australia Guide
Evidence for weight loss: how strong is it?
- AOD-9604: Publicly available human data are limited and mixed. There is no body of large, peer-reviewed randomised trials demonstrating clinically meaningful weight loss versus placebo. Claims often rely on proposed mechanisms or small studies rather than robust outcomes.
- Semaglutide: Multiple large randomised trials (e.g., STEP program) show average weight loss around 10-15% with 2.4 mg weekly alongside lifestyle changes, with individual variation and known side-effect profiles.
If your goal is medically supervised, evidence-based weight loss, semaglutide currently has far stronger support than AOD-9604.
Expected results and timeline
- AOD-9604: No consistent, validated timeline for meaningful weight loss in humans.
- Semaglutide: Appetite changes can appear within weeks; average weight loss accrues across months, with plateaus common. See: Semaglutide Results Timeline.
Related reads: AOD-9604 Results Timeline · Weight Loss Injections Australia
Safety and side effects
AOD-9604
- Safety data in large, long-term human studies are limited.
- Product quality varies widely outside regulated channels; contamination and mislabelling risks exist in the grey market.
- Sporting bodies have previously treated unapproved substances cautiously; always check current rules if you are an athlete.
Deep dives: AOD-9604 Side Effects · Counterfeit Peptides Australia
Semaglutide
- Common: nausea, vomiting, diarrhoea/constipation, reduced appetite—often dose-dependent and transient.
- Serious but uncommon: gallbladder issues, pancreatitis; rodent thyroid C-cell tumour signal—contraindicated with personal/family history of medullary thyroid carcinoma or MEN2.
- See: Semaglutide Side Effects · Ozempic Side Effects · Wegovy Side Effects
Legality and access in Australia
- AOD-9604: Not TGA-approved for weight loss. Any therapeutic use occurs under unapproved medicine pathways with a registered health professional. Personal importation and online “research” sales carry seizure and safety risks. Learn more: Is AOD-9604 Legal in Australia? · Buy AOD-9604 Australia.
- Semaglutide: Prescription-only medicine. Ozempic (diabetes) and Wegovy (weight management) are TGA-approved; supply constraints may occur. Learn more: Buy Semaglutide Australia · Semaglutide Prescription Australia.
Cost and ongoing care
Pricing varies by clinic, brand, dose and follow-up. Evidence-based care includes eligibility screening, dose titration, side-effect management and support for lifestyle change.
- Semaglutide: See Semaglutide Cost Australia, Wegovy Cost Australia, Ozempic Cost Australia.
- AOD-9604: See AOD-9604 Cost Australia. Be cautious with low-cost grey-market sources.
Provider comparisons: Peptide Clinics Australia · Online Peptide Clinic Australia · Peptide Clinic Cost Australia
Who each may suit
- Semaglutide (Wegovy): Adults with obesity, or overweight with weight-related comorbidities, when combined with lifestyle changes and medical supervision.
- AOD-9604: Given the lack of robust human evidence and unapproved status, many clinicians do not recommend it as a primary weight-loss therapy.
Related comparisons: Semaglutide vs Tirzepatide · Wegovy vs Mounjaro · Cagrilintide vs Semaglutide
Common red flags in marketing
- Before/after photos with no clinical context or timeframes.
- “Research chemical” sales pitched as medical treatments without prescriptions.
- Claims that AOD-9604 equals or exceeds GLP-1 results without peer-reviewed human data.
Helpful resources: Peptide Advertising Laws Australia · Peptide Reviews Guide · Before & After Guide
Alternatives and related options
- Other GLP-1/GIP medicines: What Is Tirzepatide? · Tirzepatide for Weight Loss
- Amylin-based research: What Is Cagrilintide? · Cagrilintide for Weight Loss
- Education hubs: Weight Loss Injections Australia · GLP-1 Australia Guide · Peptide Therapy Australia
Frequently asked questions
Which is better for weight loss: AOD-9604 or semaglutide?
Semaglutide. It has strong clinical evidence and TGA approval. AOD-9604 lacks robust human weight-loss data.
Can I use AOD-9604 and semaglutide together?
Do not combine therapies without medical supervision. Discuss risks, benefits and evidence with a qualified prescriber.
Is AOD-9604 legal in Australia?
It is not TGA-approved for obesity. Any therapeutic use would be under unapproved pathways. Be cautious with online sellers and import claims.
What side effects should I expect with semaglutide?
Mostly gastrointestinal symptoms during dose titration. Review detailed risks here: Semaglutide Side Effects.
How do I get prescribed semaglutide in Australia?
Assessment by a clinician is required. Start here: Semaglutide Prescription Australia or use the form below.
Final takeaway
For “aod 9604 vs semaglutide,” semaglutide is the evidence-based, TGA-approved option for medical weight management. AOD-9604 remains an unapproved compound without comparable human efficacy data. If you are pursuing safe, sustainable weight loss, speak with a qualified provider and prioritise treatments supported by robust trials.
Get guidance from a legitimate Australian provider
Use this form to request a call or email about evidence-based weight-management options, including GLP-1 therapy and alternatives. A clinician or care coordinator can discuss eligibility, costs and next steps.
Prefer to read first? See our hubs: Weight Loss Injections Australia · GLP-1 Australia Guide